Axsome Therapeutics (AXSM) Revenue (2022 - 2026)
Axsome Therapeutics (AXSM) reported Revenue of $218.38 million for Q2 2026, up 45.5% from $150.04 million a year earlier and up 14.2% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Revenue (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Axsome Therapeutics' Revenue came in at $776.57 million, up 56.9% year-over-year; for FY2025, it was $638.5 million, up 65.5% from FY2024.
- Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 133.7% (FY2022 to FY2025).
- By year, Revenue came in at $385.69 million in FY2024 (+42.5%), $270.6 million in FY2023 (+440.8%) and $50.04 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Revenue in data going back to Q2 2022.
- Year over year, Revenue has now increased in each of the last nine quarters, with growth averaging 64.1% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q2 2023 (growth of 429.5%); the low point was Q1 2024 (a decline of 20.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $191.2 million (Q1 2026), $196 million (Q4 2025) and $170.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Axsome Therapeutics | 9.64 Bn | 8.37 Bn | 204.81 Mn | 218.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218.38 Mn |
| Mar 31, 2026 | 191.20 Mn |
| Dec 31, 2025 | 196.00 Mn |
| Sep 30, 2025 | 170.99 Mn |
| Jun 30, 2025 | 150.04 Mn |
| Mar 31, 2025 | 121.46 Mn |
| Dec 31, 2024 | 118.77 Mn |
| Sep 30, 2024 | 104.76 Mn |
| Jun 30, 2024 | 87.17 Mn |
| Mar 31, 2024 | 75.00 Mn |
| Dec 31, 2023 | 71.53 Mn |
| Sep 30, 2023 | 57.79 Mn |
| Jun 30, 2023 | 46.70 Mn |
| Mar 31, 2023 | 94.58 Mn |
| Dec 31, 2022 | 24.37 Mn |
| Sep 30, 2022 | 16.85 Mn |
| Jun 30, 2022 | 8.82 Mn |
API Access
Axsome Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();